WTC
IMGN

WhitTier Trust Company’s Immunogen Inc IMGN Stock Holding History

WhitTier Trust Company’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-626
Closed -$3K – 1219
2022
Q3 		$3K Hold
626
– – ﹤0.01% 1023
2022
Q2 		$3K Hold
626
– – ﹤0.01% 1050
2022
Q1 		$3K Hold
626
– – ﹤0.01% 1047
2021
Q4 		$5K Buy
626
+425
+211% +$2.64K ﹤0.01% 984
2021
Q3 		$1K Buy
+201
New +$1.16K ﹤0.01% 1107

Other funds holding IMGN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

WhitTier Trust Company's IMGN Position: Q4 2022 in Review

WhitTier Trust Company sold out of Immunogen Inc (IMGN) in Q4 2022, closing a stake of 626 shares — an estimated $3K sold.

WhitTier Trust Company first reported a position in IMGN in Q3 2021 and held it in 5 quarters. The position peaked at $5K in Q4 2021. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

  • WhitTier Trust Company reported no remaining Immunogen Inc position as of Q4 2022 after selling out during the quarter.
  • WhitTier Trust Company sold 626 Immunogen Inc shares in Q4 2022, an estimated $3K.
  • WhitTier Trust Company first reported a position in Immunogen Inc in Q3 2021 and held it in 5 quarters.
  • WhitTier Trust Company's Immunogen Inc position peaked at $5K in Q4 2021.
  • 204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on WhitTier Trust Company's 13F filing for Q4 2022, filed 25 Jan 2023.